Patent details

EP3914257 Title: COMBINATION OF A BCL-2/BCL-XL INHIBITOR WITH OSIMERTINIB

Basic Information

Publication number:
EP3914257
PCT Application Number:
CN2021084970
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP217548825
PCT Publication Number:
WO2021204060
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF A BCL-2/BCL-XL INHIBITOR WITH OSIMERTINIB
French Title of Invention:
COMBINAISON D'UN INHIBITEUR DE BCL-2/BCL-XL AVEC L'OSIMERTINIB
German Title of Invention:
KOMBINATION VON EINEM BCL-2/BCL-XL-INHIBITOR MIT OSIMERTINIB
SPC Number:

Dates

Filing date:
01/04/2021
Grant date:
27/12/2023
EP Publication Date:
01/12/2021
PCT Publication Date:
14/10/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/12/2023
EP B1 Publication Date:
27/12/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/04/2024
Expiration date:
01/04/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/12/2023
 
 

Name:
Ascentage Pharma (Suzhou) Co., Ltd.
Address:
Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, China (CN)

Name:
Ascentage Pharma Group Corp Limited
Address:
9/F., Wah Yuen Building 149 Queen's Road Central, Hong Kong 999077, China (CN)

Inventor

1

Name:
YANG, Dajun
Address:
China (CN)

2

Name:
ZHAI, Yifan
Address:
China (CN)

Priority

1

Priority Number:
PCT/CN2020/084145
Priority Date:
10/04/2020
Priority Country:
World Intellectual Property Office (WIPO) (WO)

2

Priority Number:
202110344288
Priority Date:
31/03/2021
Priority Country:
China (CN)

Classification

IPC classification:
A61K 31/675; A61P 35/04; A61P 35/00; A61K 45/06; A61K 31/519; A61K 31/506; A61K 31/496; A61K 31/337; A61K 31/407;

Publication

European Patent Bulletin

Issue number:
202352
Publication date:
27/12/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages